https://www.zacks.com/stock/news/2274303/here-s-why-you-should-buy-align-technology-algn-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2274303
May 15, 2024 - Investors are optimistic about Align Technology (ALGN) led by expansion in new geographies and upbeat guidance.
zc:-5643515677157133861
0
https://www.zacks.com/stock/news/2273683/philips-phg-gets-fda-recall-for-trilogy-ventilator-glitch?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2273683
May 14, 2024 - Philips' (PHG) software update for Trilogy Evo ventilators is set to mitigate a possible power malfunction and gets FDA Class I recall identification, as it may cause serious harm.
zc:-5523840411501848332
0
https://www.zacks.com/stock/news/2272310/amn-healthcare-amn-q1-earnings-and-revenues-beat-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-2272310
May 10, 2024 - AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall first-quarter performance.
zc:-952703907939396861
0
https://www.zacks.com/stock/news/2271721/quidelortho-qdel-q1-earnings-beat-estimates-margins-fall?cid=CS-ZC-FT-analyst_blog|earnings_article-2271721
May 09, 2024 - QuidelOrtho's (QDEL) first-quarter results reflect growth in revenues, excluding the COVID-19 revenue impact.
zc:202981706207042544
0
https://www.zacks.com/stock/news/2270793/nevro-s-nvro-q1-earnings-and-sales-beat-estimates-margins-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2270793
May 08, 2024 - Nevro's (NVRO) first-quarter earnings and revenues surpass their respective Zacks Consensus Estimate. The company incurs a loss in the operating level.
zc:5894261326283499672
0
https://www.zacks.com/stock/news/2270706/masimo-masi-q1-earnings-beat-estimates-24-eps-view-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2270706
May 08, 2024 - Masimo's (MASI) Q1 healthcare revenues reflect strong sensor orders, which were completely offset by lower capital equipment purchases. Sensor production in Malaysia is likely to improve Healthcare gross margin.
zc:5520217115975240655
0
https://www.zacks.com/stock/news/2269766/quest-diagnostics-dgx-grows-in-digital-pathology-with-new-deal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2269766
May 07, 2024 - Quest Diagnostics' (DGX) pathology laboratories nationwide are set to get a boost with PathAI's AISight digital pathology image management system.
zc:-8319490038221686419
0
https://www.zacks.com/stock/news/2268227/hologic-s-holx-q2-earnings-beat-estimates-2024-view-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2268227
May 03, 2024 - Hologic's (HOLX) GYN Surgical Q2 performance was driven by strong results from MyoSure and Fluent Fluid Management.
zc:-751681654834279137
0
https://www.zacks.com/stock/news/2268160/teleflex-tfx-q1-earnings-beat-estimates-margins-rise?cid=CS-ZC-FT-analyst_blog|earnings_article-2268160
May 03, 2024 - Teleflex's (TFX) first-quarter 2024 results reflect growth across the majority of the company's product families in EMEA.
zc:-6172596859702496390
0
https://www.zacks.com/stock/news/2267265/reasons-to-retain-quest-diagnostics-dgx-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2267265
May 02, 2024 - Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.
zc:6222913646133829751
0